Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ)

被引:0
作者
Junko Yasumura
Masato Yashiro
Nami Okamoto
Kosuke Shabana
Hiroaki Umebayashi
Naomi Iwata
Yuka Okura
Tomohiro Kubota
Masaki Shimizu
Minako Tomiita
Yasuo Nakagishi
Kenichi Nishimura
Ryoki Hara
Mao Mizuta
Takahiro Yasumi
Fumiya Yamaide
Hiroyuki Wakiguchi
Masao Kobayashi
Masaaki Mori
机构
[1] Hiroshima University Graduate School of Biomedical and Health Sciences,Department of Pediatrics
[2] Okayama University Hospital,Department of Pediatrics
[3] Osaka Medical College,Department of Pediatrics
[4] Miyagi Children’s Hospital,Department of General Pediatrics
[5] Department of Immunology and Infectious Diseases,Department of Pediatrics
[6] Aichi Children’s Health and Medical Center,Department of Pediatrics
[7] Department of Pediatrics,Department of Allergy and Rheumatology
[8] KKR Sapporo Medical Center,Department of Pediatric Rheumatology
[9] Kagoshima University Hospital,Department of Pediatrics
[10] Graduate School of Medical Sciences,Department of Pediatrics
[11] Kanazawa University,Department of Pediatrics
[12] Chiba Children’s Hospital,Department of Pediatrics
[13] Hyogo Prefectural Kobe Children’s Hospital,Department of Lifetime Clinical Immunology
[14] Yokohama City University Graduate School of Medicine,undefined
[15] Kyoto University Graduate School of Medicine,undefined
[16] Chiba University Graduate School of Medicine,undefined
[17] Yamaguchi University Graduate School of Medicine,undefined
[18] Graduate School of Medical and Dental Sciences,undefined
[19] Tokyo Medical and Dental University,undefined
来源
Pediatric Rheumatology | / 17卷
关键词
Juvenile idiopathic arthritis; Uveitis; Epidemiology; Asian;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Individual and environmental determinants associated with longer times to access pediatric rheumatology centers for patients with juvenile idiopathic arthritis, a JIR cohort study
    Chausset, Aurelie
    Lambert, Celine
    Belot, Alexandre
    Merlin, Etienne
    Cannizzaro, Elvira
    Kone-Paut, Isabelle
    Ballot, Claire
    Devauchelle, Valerie
    Poignant, Sylvaine
    Carlomagno, Raffaella
    Lohse, Anne
    Barbier, Catherine
    Despert, Veronique
    Carbasse, Aurelia
    Sparsa, Laetitia
    Adank, Eva
    Vanoni, Federica
    Reumaux, Heloise
    Pillet, Pascal
    Kaiser, Daniela
    Hofer, Michael
    Freychet, Caroline
    Schott, Anne-Marie
    PEDIATRIC RHEUMATOLOGY, 2023, 21 (01)
  • [42] Individual and environmental determinants associated with longer times to access pediatric rheumatology centers for patients with juvenile idiopathic arthritis, a JIR cohort study
    Aurélie Chausset
    Céline Lambert
    Alexandre Belot
    Etienne Merlin
    Elvira Cannizzaro
    Isabelle Kone-Paut
    Claire Ballot
    Valérie Devauchelle
    Sylvaine Poignant
    Raffaella Carlomagno
    Anne Lohse
    Catherine Barbier
    Véronique Despert
    Aurélia Carbasse
    Laetitia Sparsa
    Eva Adank
    Federica Vanoni
    Héloise Reumaux
    Pascal Pillet
    Daniela Kaiser
    Michael Hofer
    Caroline Freychet
    Anne-Marie Schott
    Pediatric Rheumatology, 21
  • [43] A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
    Athimalaipet V Ramanan
    Andrew D Dick
    Diana Benton
    Sandrine Compeyrot-Lacassagne
    Dalia Dawoud
    Ben Hardwick
    Helen Hickey
    Dyfrig Hughes
    Ashley Jones
    Patricia Woo
    Clive Edelsten
    Michael W Beresford
    Trials, 15
  • [44] A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)
    Ramanan, Athimalaipet V.
    Dick, Andrew D.
    Benton, Diana
    Compeyrot-Lacassagne, Sandrine
    Dawoud, Dalia
    Hardwick, Ben
    Hickey, Helen
    Hughes, Dyfrig
    Jones, Ashley
    Woo, Patricia
    Edelsten, Clive
    Beresford, Michael W.
    TRIALS, 2014, 15
  • [45] Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany
    Heiligenhaus, Arnd
    Klotsche, Jens
    Niewerth, Martina
    Horneff, Gerd
    Ganser, Gerd
    Haas, Johannes-Peter
    Minden, Kirsten
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [46] Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany
    Arnd Heiligenhaus
    Jens Klotsche
    Martina Niewerth
    Gerd Horneff
    Gerd Ganser
    Johannes-Peter Haas
    Kirsten Minden
    Arthritis Research & Therapy, 22
  • [47] Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan
    Kubota, Tomohiro
    Takei, Syuji
    Shimizu, Masaki
    Yasumura, Junko
    Nakagishi, Yasuo
    Kizawa, Toshitaka
    Yashiro, Masato
    Wakiguchi, Hiroyuki
    Yamasaki, Yuichi
    Kawano, Yoshifumi
    MODERN RHEUMATOLOGY, 2018, 28 (05) : 826 - 831
  • [48] CYTOKINE PROFILE (TNFA, IL1B, IL6, IL10) AND ITS ASSOCIATION WITH CLINICAL FEATURES IN JUVENILE IDIOPATHIC ARTHRITIS
    Nazarova, L. Sh
    Danilko, K., V
    Malievsky, V. A.
    Viktorova, T. V.
    Rakhmatullina, I. R.
    PERIODICO TCHE QUIMICA, 2019, 16 (32): : 583 - 597
  • [49] Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)
    Ramanan, Athimalaipet, V
    Guly, Catherine M.
    Keller, Stuart Y.
    Schlichting, Douglas E.
    de Bono, Stephanie
    Liao, Ran
    Quartier, Pierre
    TRIALS, 2021, 22 (01)
  • [50] Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)
    Athimalaipet V. Ramanan
    Catherine M. Guly
    Stuart Y. Keller
    Douglas E. Schlichting
    Stephanie de Bono
    Ran Liao
    Pierre Quartier
    Trials, 22